VACCINIA VIRUS ENCODES A POLYPEPTIDE HOMOLOGOUS TO EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH-FACTOR
VACCINIA VIRUS ENCODES A POLYPEPTIDE HOMOLOGOUS TO EPIDERMAL GROWTH-FACTOR AND TRANSFORMING GROWTH-FACTOR
复制标题
DOI:
10.1038/313491a0
复制
发表时间:
1985-01-01
期刊:
影响因子:
64.8
通讯作者:
TODARO, GJ
中科院分区:
文献类型:
--
作者:
BROWN, JP;TWARDZIK, DR;TODARO, GJ
Epidermal growth factor (EGF) and transforming growth factor type I (TGF) are polypeptides of 53 and 50 amino acid residues, respectively1,2. Both bind to EGF receptor, a 1,200-residue transmembranous glycoprotein3, leading to phosphorylation of the receptor, enhancement of its tyrosine-specific kinase activity and ultimately to stimulation of cell growth4,5. We report here that a 140-residue polypeptide encoded by one of the early genes of vaccinia virus (VV)6is related closely to EGF and TGF. The presence of putative signal and transmembranous sequences further suggests that the viral protein might be an integral membrane protein, but that, as in the case of EGF itself7,8, the membrane-associated form may be the precursor of a soluble growth factor. Production of EGF-like growth factors by virally infected cells could account for the proliferative diseases associated with members of the poxvirus family such as Shope fibroma virus9, Yaba tumour virus10, and molluscum contagiosum virus (MCV)11.